Repositório Científico do Instituto Nacional de Saúde >
Departamento de Doenças Infecciosas >
DDI - Artigos em revistas internacionais >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.18/645

Título: Clostridium difficile infection in Europe: a hospital-based survey
Autor: Bauer, MP
Notermans, DW
van Benthem, BH
Brazier, JS
Wilcox, MH
Rupnik, M
Monnet, DL
van Dissel, JT
Kuijper, EJ
Machado, Jorge
Palavras-chave: Clostridium Difficile
Infection
Hospital Infection
Hospital
Nosocomial
Europe
Infecções Gastrointestinais
Issue Date: Jan-2011
Editora: Elsevier
Citação: Lancet. 2011 Jan 1;377(9759):63-73
Resumo: BACKGROUND: Little is known about the extent of Clostridium difficile infection in Europe. Our aim was to obtain a more complete overview of C difficile infection in Europe and build capacity for diagnosis and surveillance. METHODS: We set up a network of 106 laboratories in 34 European countries. In November, 2008, one to six hospitals per country, relative to population size, tested stool samples of patients with suspected C difficile infection or diarrhoea that developed 3 or more days after hospital admission. A case was defined when, subsequently, toxins were identified in stool samples. Detailed clinical data and stool isolates were collected for the first ten cases per hospital. After 3 months, clinical data were followed up. FINDINGS: The incidence of C difficile infection varied across hospitals (weighted mean 4·1 per 10,000 patient-days per hospital, range 0·0-36·3). Detailed information was obtained for 509 patients. For 389 of these patients, isolates were available for characterisation. 65 different PCR ribotypes were identified, of which 014/020 (61 patients [16%]), 001 (37 [9%]), and 078 (31 [8%]) were the most prevalent. The prevalence of PCR-ribotype 027 was 5%. Most patients had a previously identified risk profile of old age, comorbidity, and recent antibiotic use. At follow up, 101 (22%) of 455 patients had died, and C difficile infection played a part in 40 (40%) of deaths. After adjustment for potential confounders, an age of 65 years or older (adjusted odds ratio 3·26, 95% CI 1·08-9·78; p=0·026), and infection by PCR-ribotypes 018 (6·19, 1·28-29·81; p=0·023) and 056 (13·01; 1·14-148·26; p=0·039) were significantly associated with complicated disease outcome. INTERPRETATION: PCR ribotypes other than 027 are prevalent in European hospitals. The data emphasise the importance of multicountry surveillance to detect and control C difficile infection in Europe.
Descrição: Comment in Lancet. 2011 Jan 1;377(9759):8-9. Lancet. 2011 Apr 23;377(9775):1407.
Arbitragem científica: yes
URI: http://hdl.handle.net/10400.18/645
ISSN: 0140-6736
Versão do Editor: http://www.sciencedirect.com/science/article/pii/S0140673610612664
Appears in Collections:DDI - Artigos em revistas internacionais

Files in This Item:

File Description SizeFormat
Clostridium difficile infection in Europe a hospital based survey Lancet 2011.pdf919,7 kBAdobe PDFView/Open
Restrict Access. You can request a copy!
Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  © 2010 www.insa.pt - Todos os direitos reservados | Feedback Ministério da Saúde

Estamos no RCAAP Governo Português separator Ministério da Educação e Ciência  Fundação para a Ciência e a Tecnologia

Financiado por:

POS_C UE